Drug Type Small molecule drug |
Synonyms AR-12286/travoprost, Travoprost/AR-12286, Verosudil/travoprost + [1] |
Target |
Action agonists, inhibitors |
Mechanism PTGFR agonists(Prostanoid FP receptor agonists), ROCK inhibitors(Rho-associated kinases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H35F3O6 |
InChIKeyMKPLKVHSHYCHOC-AHTXBMBWSA-N |
CAS Registry157283-68-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 2 | United States | 01 Dec 2011 |